Compared with the pre-vaccination period of Nov. 29 to Dec. 12, 2020, COVID-19 incidence during April 18 to May 1, 2021, was 69% lower among adults overall, and 79%, 71% and 66% lower among persons aged 65 and over, 50-64 and 18-49, respectively, according to a report released today by the Center for Disease Control and Prevention. The study also demonstrated similar declines in COVID-19 hospitalizations, emergency department visits and deaths after the launch of the U.S. vaccination campaign. “The greater decline in COVID-19 morbidity and mortality in older adults, the age group with the highest vaccination rates, demonstrates the potential impact of increasing population-level vaccination coverage,” the authors said.
 
According to a CDC study released yesterday, the Pfizer and Moderna mRNA vaccines reduce the risk of infection by 91% for fully vaccinated people, based on four weeks of additional data from health care workers, first responders and other essential workers.

 

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…